ARPO | Aerpio Pharmaceuticals Inc

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Profile

Category: Consumer goods

• Industry: Biotechnology

Quick infos

• Headquarters:   Blue Ash, Ohio, United States

Trade prices

• Volume:
• Market Cap: 97.59M
• Prev closed:
• Open:
• High:
• Low:
• 52 week low:
• 52 week high:
• Dividends:

Next ER: August 11, 2021 

Top Stories (ARPO)

Earnings History

Date	EPS / Forecast	Revenue / Forecast
November 16, 2021
August 11, 2021	-0.09 / -0.06	- / -
May 17, 2021	-0.09 / -0.09	- / -
March 11, 2021	-0.1 / -0.1334	- / 2M
November 10, 2020	-0.12 / -0.14	- / -
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Aug 11, 2021		2.0200		2.0700	2.0700	2.0000		929.98K	0%
Aug 10, 2021		2.0200		2.1400	2.1444	2.0150		1.21M	-5.16%
Aug 9, 2021		2.1300		2.0700	2.1800	2.0700		926.09K	3.40%
Aug 6, 2021		2.0600		2.0500	2.0700	1.9900		543.23K	0.98%
Aug 5, 2021		2.0400		2.0000	2.0650	2.0000		599.57K	2%
Aug 4, 2021		2.0000		2.0000	2.0400	1.9750		537.80K	-0.99%
Aug 3, 2021		2.0200		2.0400	2.0500	1.9950		566.29K	-1.46%
Aug 2, 2021		2.0500		2.0600	2.0800	1.9900		741.67K	1.49%
Jul 30, 2021		2.0200		2.1200	2.1200	2.0200		605.85K	-4.72%
Jul 29, 2021		2.1200		2.1700	2.2700	2.1000		830.75K	-1.85%
view more

Show all

News

News for (ARPO)

• Greater Cincinnati pharma firms stock plummets
  bizjournals.com Oct 15, 2020 1:41 pm
• Has Aerpio Pharmaceuticals (ARPO) Outpaced Other Medical Stocks This Year?
  finance.yahoo.com Oct 15, 2020 11:30 am
• Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
  finance.yahoo.com Oct 15, 2020 9:00 am
• New Strong Buy Stocks For May 21st
  finance.yahoo.com Oct 15, 2020 8:01 am
• Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update
  finance.yahoo.com Oct 15, 2020 7:00 am
• Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease
  finance.yahoo.com Oct 15, 2020 7:00 am
• Aerpio Pharmaceuticals Announces Review of Strategic Alternatives
  finance.yahoo.com Oct 15, 2020 5:00 am
• 
  Aerpio Pharms EPS misses by $0.04, revenue in-line
  seekingalpha.com Aug 12, 2020 8:04 pm
• Aerpio Reports Second Quarter 2020 Financial Results and Provides Business Update
  finance.yahoo.com Aug 12, 2020 8:00 am
• 
  Aerpio Pharma up big on funding of razuprotafib study in COVID-19
  seekingalpha.com Aug 5, 2020 8:26 pm
• The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
  finance.yahoo.com Aug 5, 2020 7:35 am
• Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know
  finance.yahoo.com Jun 29, 2020 5:50 pm
• 
  Aerpio launches mid-stage study of razuprotafib in glaucoma
  seekingalpha.com Jun 24, 2020 9:28 pm
• Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial
  finance.yahoo.com Jun 24, 2020 8:00 am
• Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year?
  finance.yahoo.com Jun 12, 2020 11:30 am
• New Strong Buy Stocks for April 24th
  finance.yahoo.com Apr 24, 2020 7:24 am
• Immunovant (IMVT) Catches Eye: Stock Jumps 5%
  finance.yahoo.com Apr 16, 2020 8:39 am
• Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know
  finance.yahoo.com Jun 19, 2020 5:45 pm
• New Strong Buy Stocks For June 15th
  finance.yahoo.com Jun 15, 2020 10:07 am
• Company News for May 29, 2020
  finance.yahoo.com May 29, 2020 9:59 am

Talk about Aerpio Pharmaceuticals Inc below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

Other ER on Aug 11, 2021 (Same day)